References of "LEBAS, Eglantine"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailChronic mucocutaneous herpes simplex virus and varicella zoster virus infections
Wauters, Odile ULg; Lebas, Eglantine ULg; Nikkels, Arjen ULg

in Journal of the American Academy of Dermatology (2012)

Detailed reference viewed: 25 (3 ULg)
Full Text
See detailLa gestion des médicaments photosensibilisants
DEZFOULIAN, Bita ULg; LEBAS, Eglantine ULg; DE SCHAETZEN VAN BRIENEN, Virginie ULg et al

in Skin Inc (2012), 15(3), 16-21

L'arrivée de l'été nous confronte à nouveau aux réactions médicamenteuses photo-induites. Deux types de réactions photosensibles sont rencontrés : la photoallergie médicamenteuse, plutôt rare, et la ... [more ▼]

L'arrivée de l'été nous confronte à nouveau aux réactions médicamenteuses photo-induites. Deux types de réactions photosensibles sont rencontrés : la photoallergie médicamenteuse, plutôt rare, et la phototoxicité médicamenteuse, beaucoup plus fréquente. Ces réactions peuvent se produire aussi bien avec des médicaments topiques que systémiques. La liste des médicaments classiquement en cause est actuellement enrichie de nouveaux médicaments tels que le voriconazole, l'ipilimumab et le vémurafénib. Cette revue présente les pricipaux mécanismes en cause, une mise à jour de la liste des médicaments photosensibilisants et la gestion prophylactique et thérapeutique des patients. [less ▲]

Detailed reference viewed: 19 (1 ULg)
Full Text
Peer Reviewed
See detailLes effets cutanés indésirables des antagonistes du TNF alpha
FAILLA, Valérie ULg; SABATIELLO, Murielle ULg; LEBAS, Eglantine ULg et al

in Revue Médicale de Liège (2012)

The TNF alpha antagonists, including adalimumab, etanercept and infliximab, represent a class of anti-inflammatory and immunosuppressive drugs. Although cutaneous adverse effects are uncomon, they are ... [more ▼]

The TNF alpha antagonists, including adalimumab, etanercept and infliximab, represent a class of anti-inflammatory and immunosuppressive drugs. Although cutaneous adverse effects are uncomon, they are varied. There is no particular risk profile to develop cutaneous adverse effects. The principal acute side effects are injection site reactions and pruritus. The major long term cutaneous side effects are infectious and inflammatory conditions. Neoplastic skin diseases are exceptional. the association with other immunosuppressive agents can increase the risk of developing cutaneous adverse effects. Some adverse effects, such as lupus erythematosus, require immediate withdrawal of the biological treatment, while in other cases temporary withdrawal is sufficient. The majority of the other cutaneous adverse effects can be dealt without interrupting biologic treatment. Preclinical and clinical investigations revealed that the new biologics, aiming IL12/23, IL23 and IL17, present a similar profile of cutaneous adverse effects, although inflammatory skin reactions may be less often encountered compared to TNF alpha antagonists. [less ▲]

Detailed reference viewed: 105 (18 ULg)
Full Text
Peer Reviewed
See detailCOMPLICATIONS DERMATOLOGIQUES DES TATOUAGES DEFINITIFS ET TEMPORAIRES
CAUCANAS, MARIE; EL HAYDERI, Lara ULg; LEBAS, Eglantine ULg et al

in Annales de Dermatologie et de Vénéréologie (2011)

Detailed reference viewed: 14 (2 ULg)
Full Text
Peer Reviewed
See detailViral infections of the pubis
CASTRONOVO, Charlotte ULg; LEBAS, Eglantine ULg; NIKKELS-TASSOUDJI, Nazli ULg et al

in International Journal of STD & AIDS (2011)

There are no demographic data published on those with viral infections of the pubis (VIPs). We conducted a two-year prospective study to collect demographic information on patient with VIPs. Data were ... [more ▼]

There are no demographic data published on those with viral infections of the pubis (VIPs). We conducted a two-year prospective study to collect demographic information on patient with VIPs. Data were gathered on age, sex, diagnosis, low (<=10) or high (>10) lesion number, symptoms, how the patien discovered the lesions, localization, lesions beyond the pubis, risk factors, shaving habits, human papillomavirus vaccination status and treatment. In a total of 61 patients, molluscum contagiosum (MC) was indentified in 71 %, condylomata acuminata (CA) in 11 %, concomitant MC and CA infections in 11 % and herpes simplex virus (HSV) infection in 4.8 %. Shaving represented a risk factor for a high lesion number, but not for the extension beyond the pubis. MC, CA and HSV infections affecting the pubis are uncommon and often symptomatic. As they may represent a hidden source of infection we recommend thourough inspection of the pubis during routine skin examination. [less ▲]

Detailed reference viewed: 12 (2 ULg)
Full Text
See detailVirale orale infecties
Lebas, Eglantine ULg; Wauters, Odile ULg; Sabatiello, Murielle ULg et al

in Nederlands tijdschrift voor dermatologie en venereologie (2009), 19(9), 500-503

Detailed reference viewed: 68 (24 ULg)
Full Text
Peer Reviewed
See detailColite aigue revelant une maladie de Wegener
Lebas, Eglantine ULg; Gielen, Sabine ULg; Nguyen, Minh Ngoc ULg et al

in Revue Médicale de Liège (2006), 61(3), 163-8

We report the case of a 52 year old man who was hospitalized within a context of a persistent deterioration of his general condition. He was suspected of having a chronic inflammatory colitis. A pulmonary ... [more ▼]

We report the case of a 52 year old man who was hospitalized within a context of a persistent deterioration of his general condition. He was suspected of having a chronic inflammatory colitis. A pulmonary radiography revealed the presence of voluminous bilateral excavated masses with hydro-aerical levels. After having refuted among others a suspicion of tuberculosis, the results of a thoracic percutaneous transpleural lung aspiration by needle under tomodensitometric control steered our diagnosis towards a vascularitis of the Wegener disease type. A treatment with corticotherapy in large doses completed with cyclophosphamid allowed for clinical, biological and radiological improvement. Wegener's granulomatosis usually starts in an insidious manner with febrile episodes and an impairment of the general condition associated with inflammatory biological signs, as observed in our patient. After these warning symptoms, come ORL and/or pulmonary and/or renal impairment, which represent the classical triad of diffused GW. However a certain number of particularities unusual for that diagnosis characterized our patient and prompted the discussion of this case. [less ▲]

Detailed reference viewed: 251 (8 ULg)
Full Text
Peer Reviewed
See detailL'adiponectine: une nouvelle adipocytokine.
Lebas, Eglantine ULg; Paquot, Nicolas ULg; Scheen, André ULg

in Revue Médicale de Liège (2003), 58(9), 554-8

Adipose tissue is not simply a store of excess energy, but also secretes a variety of proteins into circulating blood that influence systemic metabolism. These include tumor necrosis factor (TNF-alpha ... [more ▼]

Adipose tissue is not simply a store of excess energy, but also secretes a variety of proteins into circulating blood that influence systemic metabolism. These include tumor necrosis factor (TNF-alpha), plasminogen activator inhibitor type 1 (PAI-1), leptin, resistine and adiponectin. These are collectively known as adipocytokines. Adiponectin (also referred to as AdipoQ, Acrp 30, apM1 or GBP28) is a novel adipose-specific protein. A recent genome study mapped a susceptibility locus for type 2 diabetes and the metabolic syndrome on chromosome 3q27, where the adiponectin gene is located. Adiponectin is a peculiar adipocytokine because in contrast to the markedly increased levels of many others, as leptin or TNF-alpha, its level is reduced in obesity and type 2 diabetes. The administration of thiazolidinediones, which are synthetic PPARs-gamma ligands, significantly increases the plasma adiponectin concentrations, an effect that could improve insulin sensitivity. Thus, the administration of adiponectin may provide a novel treatment modality for insulin resistance and type 2 diabetes. [less ▲]

Detailed reference viewed: 139 (6 ULg)